investigated NSCLC patients with typical T cell exhaustion phenotypic characteristics and found that PD-1high expression on CD8+ TILs correlated with heightened tumor recognition capability and anti-PD-1 treatment response (48). The gene discussed is CD8A; the disease is neoplasm.